H.Res. 279 · 112th Congress

Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.

Stage
In committee
Introduced
2011-05-25
Latest action
2011-06-03 · Referred to the Subcommittee on Health.

Summary

Declares that the House of Representatives seeks to raise public awareness of the risks associated with anticoagulant medications.

Encourages pharmaceutical manufacturers and health care providers to properly communicate the risk of death associated with such drugs to their patients.